DiNAQOR AG is a biotechnology company builder that develops platform technologies and launches focused companies in tissue science, precision medicine and genetic therapies. Its portfolio includes entities such as DiNATEQ, DiNAMIQS, DiNABiOS and DAiNA; the group provides access to GMP‑compliant viral vector manufacturing and advances precision gene‑therapy programs for cardiomyopathies, heart failure and polycystic kidney disease.
AI-generated
Offering
Products & services
Outbound Leads by COHAGA
Looking for direct email addresses and phone numbers?
Leadhub delivers verified contact details and decision-makers from over 750,000 Swiss companies — management, procurement, marketing, HR.
Precise genetic therapies for cardiomyopathies, heart failure and polycystic kidney diseases; platform architecture for additional disease areas, development in collaboration with external partners.
Biotechnology company builder
Building and scaling focused biotechnology companies around differentiated technology platforms; origination, development and strategic scaling of ventures in the life sciences sector.
Precision delivery platforms
Platforms for precise drug and gene delivery, including technologies for organ- and tissue-targeted administration with improved safety and efficacy.
Vector innovation and AAV manufacturing
Development and scaling of AAV manufacturing and development platforms for GMP-compatible manufacturing and scalable viral vector production.
Human Tissue & Stem Cell Research Services
Research services with human tissue and stem cell models for drug discovery, preclinical testing and tissue-therapy development.